Compare ABLV & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ABLV | MDXH |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | China | Belgium |
| Employees | 164 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.9M | 41.1M |
| IPO Year | N/A | 2021 |
| Metric | ABLV | MDXH |
|---|---|---|
| Price | $1.11 | $0.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | 119.5K | ★ 745.7K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $30.78 |
| Revenue Next Year | N/A | $18.31 |
| P/E Ratio | $16.70 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.54 | $0.51 |
| 52 Week High | $1.77 | $5.33 |
| Indicator | ABLV | MDXH |
|---|---|---|
| Relative Strength Index (RSI) | 60.70 | 18.24 |
| Support Level | $0.83 | $0.51 |
| Resistance Level | $1.25 | $3.79 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 65.45 | 14.00 |
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.